Miami International Airport (MIA) celebrated cargo partner Amerijet’s certification for pharma excellence by IATA. Amerijet is the first U.S. all-cargo airline to receive IATA’s prestigiousCenter of Excellence for Independent Validators (CEIV) pharma certification.
In 2015, MIA was designated a pharma hub by IATA for organizing nine of its logistics providers to undergo the CEIV program. Since then, four companies at MIA have achieved the certification: Swissport (the first cargo handling company at MIA as well as the first Swissport station in North America to be certified); LATAM Cargo (the first CEIV-certified airline in the Americas); and international freight forwarding giant Kuehne & Nagle.
IATA, the trade association for the world’s airlines that represents some 265 airlines or 83 percent of total air traffic, created theCEIV program to certify that pharma products are transported in accordance with global best practices.
“Thanks to hub partners like Amerijet, MIA’s pharma trade has grown 140 percent in value since 2010 to $4.4 billion in 2016,” said Miami-Dade Aviation Director Emilio T. González. “Our pharma hub initiative, combined with our extensive global network, continues to broaden MIA’s already sizable economic impact in our community.”
Amerijet, MIA’s seventh-busiest airline for freight tonnage, plans to expand its operations at the cargo hub in 2018 with two weekly freighter flights between Brussels Airport and MIA – the world’s first two IATA-designated pharma hubs.
“This certification reconfirms our commitment to offering the highest consistent quality, professionalism and transparency to our customers. Being the first all-cargo airline from the U.S. to receive the CEIV in Pharmaceutical Logistics is a direct result of hard work and the investments we have made over the last few years to our Temperature Controlled (ATC) program,” said Vic Karjian, President and CEO of Amerijet International Airlines.